Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-05-20

FDA Approved: ESCITALOPRAM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ESCITALOPRAM (escitalopram oxalate) from Sun Pharmaceutical Industries, Inc., approving this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

SUPPL AP for ESCITALOPRAM (ESCITALOPRAM OXALATE)